Nejib Zemzemi

Nejib Zemzemi

Auto-generated profile, based on publicly available information

Nejib Zemzemi

Inria centre at the University of Bordeaux, Carmen project team. 200 Avenue de la vielle Tour, Talence Cedex 33405, France

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2013 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
GMGary Richard Mirams
Gary Richard Mirams
CAChristopher J. Arthurs
Christopher J. Arthurs
MBMiguel O. Bernabeu
Miguel O. Bernabeu
RBRafel Bordas
Rafel Bordas
JCJonathan Cooper
Jonathan Cooper
DGDavid J. Gavaghan
David J. Gavaghan
Chaste — Cancer, Heart And Soft Tissue Environment — is an open source C++ library for the computational simulation of mathematical models developed for physiology and biology. Code development has been driven by two initial applications: cardiac electrophysiology and cancer development. A large number of cardiac electrophysiology studies have been enabled and performed, including high-performance computational investigations of defibrillation on realistic human cardiac geometries. New models for the initiation and growth of tumours have been developed. In particular, cell-based simulations have provided novel insight into the role of stem cells in the colorectal crypt. Chaste is constantly evolving and is now being applied to a far wider range of problems. The code provides modules for handling common scientific computing components, such as meshes and solvers for ordinary and partial differential equations (ODEs/PDEs). Re-use of these components avoids the need for researchers to ‘re-invent the wheel’ with each new project, accelerating the rate of progress in new applications. Chaste is developed using industrially-derived techniques, in particular test-driven development, to ensure code quality, re-use and reliability. In this article we provide examples that illustrate the types of problems Chaste can be used to solve, which can be run on a desktop computer. We highlight some scientific studies that have used or are using Chaste, and the insights they have provided. The source code, both for specific releases and the development version, is available to download under an open source Berkeley Software Distribution (BSD) licence at http://www.cs.ox.ac.uk/chaste, together with details of a mailing list and links to documentation and tutorials.

24 December 2009 in Annals of Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
MBMuriel Boulakia
Muriel Boulakia
SCSerge Cazeau
Serge Cazeau
MFMiguel A. Fernández
Miguel A. Fernández
JGJean-Frédéric Gerbeau
Jean-Frédéric Gerbeau
NZNejib Zemzemi
Nejib Zemzemi

5 September 2012 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
NZNejib Zemzemi
Nejib Zemzemi
MBMiguel O Bernabeu
Miguel O Bernabeu
JSJavier Saiz
Javier Saiz
JCJonathan Cooper
Jonathan Cooper
PPPras Pathmanathan
Pras Pathmanathan
BRBlanca Rodriguez
Blanca Rodriguez
Background and Purpose: Understanding drug effects on the heart is key to safety pharmacology assessment and anti‐arrhythmic therapy development. Here our goal is to demonstrate the ability of computational models to simulate the effect of drug action on the electrical activity of the heart, at the level of the ion‐channel, cell, heart and ECG body surface potential.Experimental Approach: We use the state‐of‐the‐art mathematical models governing the electrical activity of the heart. A drug model is introduced using an ion channel conductance block for the hERG and fast sodium channels, depending on the IC50 value and the drug dose. We simulate the ECG measurements at the body surface and compare biomarkers under different drug actions.Key Results: Introducing a 50% hERG‐channel current block results in 8% prolongation of the APD90 and 6% QT interval prolongation, hERG block does not affect the QRS interval. Introducing 50% fast sodium current block prolongs the QRS and the QT intervals by 12% and 5% respectively, and delays activation times, whereas APD90 is not affected.Conclusions and Implications: Both potassium and sodium blocks prolong the QT interval, but the underlying mechanism is different: for potassium it is due to APD prolongation; while for sodium it is due to a reduction of electrical wave velocity. This study shows the applicability of in silico models for the investigation of drug effects on the heart, from the ion channel to the ECG‐based biomarkers.

1 December 2016 in EP Europace
Verified
Journal Article
Open access
PDF file
LCLouie Cardone-Noott
Louie Cardone-Noott
Alfonso Bueno-OrovioAlfonso Bueno-Orovio
Alfonso Bueno-Orovio
AMAna Mincholé
Ana Mincholé
NZNejib Zemzemi
Nejib Zemzemi
BRBlanca Rodriguez
Blanca Rodriguez
To investigate how variability in activation sequence and passive conduction properties translates into clinical variability in QRS biomarkers, and gain novel physiological knowledge on the information contained in the human QRS complex. Multiscale bidomain simulations using a detailed heart-torso human anatomical model are performed to investigate the impact of activation sequence characteristics on clinical QRS biomarkers. Activation sequences are built and validated against experimentally-derived ex vivo and in vivo human activation data. R-peak amplitude exhibits the largest variability in terms of QRS morphology, due to its simultaneous modulation by activation sequence speed, myocardial intracellular and extracellular conductivities, and propagation through the human torso. QRS width, however, is regulated by endocardial activation speed and intracellular myocardial conductivities, whereas QR intervals are only affected by the endocardial activation profile. Variability in the apico-basal location of activation sites on the anterior and posterior left ventricular wall is associated with S-wave progression in limb and precordial leads, respectively, and occasional notched QRS complexes in precordial derivations. Variability in the number of early activation sites successfully reproduces pathological abnormalities of the human conduction system in the QRS complex. Variability in activation sequence and passive conduction properties captures and explains a large part of the clinical variability observed in the human QRS complex. Our physiological insights allow for a deeper interpretation of human QRS biomarkers in terms of QRS morphology and location of early endocardial activation sites. This might be used to attain a better patient-specific knowledge of activation sequence from routine body-surface electrocardiograms.

29 November 2018 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
AKAmel Karoui
Amel Karoui
LBLaura Bear
Laura Bear
PMPauline Migerditichan
Pauline Migerditichan
NZNejib Zemzemi
Nejib Zemzemi
The electrocardiographic imaging inverse problem is ill-posed. Regularization has to be applied to stabilize the problem and solve for a realistic solution. Here, we assess different regularization methods for solving the inverse problem. In this study, we assess (i) zero order Tikhonov regularization (ZOT) in conjunction with the Method of Fundamental Solutions (MFS), (ii) ZOT regularization using the Finite Element Method (FEM), and (iii) the L1-Norm regularization of the current density on the heart surface combined with FEM. Moreover, we apply different approaches for computing the optimal regularization parameter, all based on the Generalized Singular Value Decomposition (GSVD). These methods include Generalized Cross Validation (GCV), Robust Generalized Cross Validation (RGCV), ADPC, U-Curve and Composite REsidual and Smoothing Operator (CRESO) methods. Both simulated and experimental data are used for this evaluation. Results show that the RGCV approach provides the best results to determine the optimal regularization parameter using both the FEM-ZOT and the FEM-L1-Norm. However for the MFS-ZOT, the GCV outperformed all the other regularization parameter choice methods in terms of relative error and correlation coefficient. Regarding the epicardial potential reconstruction, FEM-L1-Norm clearly outperforms the other methods using the simulated data but, using the experimental data, FEM based methods perform as well as MFS. Finally, the use of FEM-L1-Norm combined with RGCV provides robust results in the pacing site localization.

1 January 2009
Verified
Book Chapter
Closed access
PDF file
DCDominique Chapelle
Dominique Chapelle
MFMiguel A. Fernández
Miguel A. Fernández
JGJean-Frédéric Gerbeau
Jean-Frédéric Gerbeau
PMPhilippe Moireau
Philippe Moireau
JSJacques Sainte-Marie
Jacques Sainte-Marie
NZNejib Zemzemi
Nejib Zemzemi